Breast Cancer Treatment-Related Financial Burden Greater for Black vs White Women

Share this content:
data data indicate that that 58% of black women reported experiencing negative financial impact since diagnosis, compared with 39% of white women.
data data indicate that that 58% of black women reported experiencing negative financial impact since diagnosis, compared with 39% of white women.

Black women with breast cancer experience a greater negative financial impact and may have worse overall outcomes compared with white women, according to a study published in the Journal of Clinical Oncology.

Cancer care is associated with significant costs for both the insured and uninsured, white patients and racial minorities, yet there is a lack of transparency in regards to cost for patients and providers. The impact of costs associated with cancer therapy, particularly for more vulnerable patient subgroups, require further study.  

 

For this study, researchers evaluated the outcomes of 2494 young and working-age women with breast cancer diagnosed between 2008 and 2013; 49% of patients were black and 51% were white. Study participants granted investigators access to medical records and completed questionnaires that detailed socioeconomic status, demographics, access to care, health-related quality of life, and the financial impact of cancer treatment at 5 months (baseline) and 25 months postdiagnosis. 

 

Results showed that 58% of black women reported experiencing negative financial impact since diagnosis compared with 39% of white women (P <.001).

Once adjusted for age, stage at diagnosis, and treatment received, further analyses showed that black women were more likely to report significant cancer-related financial adverse events, including income loss, job loss, healthcare-related transportation barriers, healthcare-related financial barriers, and loss of health insurance.

Socioeconomic status may also be a key contributor; once factored, the impact of race on financial outcome measures was lessened. However, the effect of race still remained significant for income and job loss, transportation barriers, and overall financial impact.

The authors concluded that “an urgent need exists for research on the financial needs of diverse patients with breast cancer as well as for the development of interventions and support tools that identify and match patients to resources for financial assistance, can be delivered broadly across a variety practice settings, and are user friendly to facilitate discussions between patients and providers about addressing financial barriers to treatment.” 

Reference

Wheeler SB, Spencer JC, Pinheiro LC, et al. Financial impact of breast cancer in black versus white women [published online April 18, 2018]. J Clin Oncol. doi: 10.1200/JCO.2017.77.6310

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs